Skip to main content

Market Overview

Why Novus Therapeutics Is Trading Higher Today

Share:
Why Novus Therapeutics Is Trading Higher Today

Novus Therapeutics (NASDAQ: NVUS) shares are trading higher on Tuesday after the company announced the purchase of Anelixis Therapeutics.

Novus Therapeutics is engaged in the biotechnology sector. As a pharmaceutical company it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: Foam Platform(OP0201 and OP0202) and Surfactant Program(OP0201). OP0102 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP0201 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction.

Novus Therapeutics shares were trading up 179.68% at $1.06 on Tuesday during the time of publication. The stock has a 52-week high of $1.45 and a 52-week low of 25 cents.

 

Related Articles (NVUS)

View Comments and Join the Discussion!

Posted-In: why it's movingM&A News Penny Stocks

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com